We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KTCC:NASDAQKey Tronic Corporation Analysis

Data as of 2026-06-01 - not real-time

$3.46

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Key Tronic’s stock is trading at $3.46, comfortably above its 20‑day ($3.18) and 50‑day ($2.93) SMAs, with a bullish MACD crossover and a RSI of 68 signaling near‑overbought conditions. The price sits just below the calculated resistance of $3.47 and above the support level of $2.83, while volatility is unusually high at 47.7% over the past 30 days and beta is modest (~0.7), indicating a relatively defensive market exposure despite the “Extreme Greed” sentiment reading.
Fundamentally, the company posted a 20% YoY revenue decline to $89.6 M in Q3 FY2026, margins remain thin (gross margin ~7%, operating margin negative), and earnings are still in the red (trailing EPS –$1.60). The balance sheet is strained with $135 M of debt versus only $0.4 M of cash, yielding a debt‑to‑equity of over 130, while the book value per share stands at $9.78, creating a low price‑to‑book of 0.35. Despite a DCF‑derived fair value of $33.79, the market caps the stock at $37.6 M, suggesting a deep discount but also highlighting the risk of a turnaround not yet materialized.*

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • price is near the technical resistance of $3.47
  • RSI is in overbought territory (~68)
  • declining volume amid weak earnings

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • potential upside if revenue stabilizes
  • low price‑to‑book provides a valuation cushion
  • high debt load restricts financial flexibility

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • DCF fair value suggests substantial upside
  • very low price‑to‑sales and price‑to‑book ratios
  • possible turnaround through cost improvements and program wins

Key Metrics & Analysis

Financial Health

Revenue Growth-20.00%
Profit Margin-4.40%
ROE-15.60%
ROA-1.56%
Debt/Equity131.45
P/B Ratio0.4
Op. Cash Flow$18.8M
Free Cash Flow$37.9M
Industry P/E41.9

Technical Analysis

TrendNeutral
RSI68.1
Support$2.83
Resistance$3.47
MA 20$3.18
MA 50$2.93
MA 200$2.95
MACDBullish
VolumeDecreasing
Fear & Greed Index93.29

Valuation

Fair Value$33.79
GradeUndervalued
TypeValue

Risk Assessment

Beta0.71
Volatility47.67%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.